m*********3
发帖数: 1425 | 1 http://www.wsj.com/articles/biogen-slashes-outlook-on-tecfidera
Shares in drug maker Biogen Inc. fell 22% on Friday, lopping about $20
billion off its market value after it disclosed a sharp slowdown in sales
growth for its flagship multiple-sclerosis pill and slashed its earnings
outlook.
It was the stock’s biggest one-day percentage drop since 2008, and its
largest decline in absolute dollars, according to FactSet.
Biogen expects 2015 revenue growth of between 6% and 8% in 2015, roughly
half t... 阅读全帖 |
|
m*********3
发帖数: 1425 | 2 一共800多，麻州400
http://www.wbur.org/2015/10/21/biogen-layoffs
The Cambridge-based drug company Biogen is shedding around 400 jobs in
Massachusetts, as part of a larger cost-cutting move.
Biogen announced on Wednesday that it will cut 11 percent of its global
workforce of nearly 8,000 employees as part of a restructuring designed to
focus the company on some of its more promising drugs.
CEO George Scangos said in an earnings call that the cuts are necessary.
“They’re good people, good employees,” he... 阅读全帖 |
|
j*****7
发帖数: 4348 | 3 Oct 27, 2008
Exelixis in the post-GSK era
We also decided to add more Exelixis (EXEL), which is in the process of
transforming into a “leaner and meaner” company, according to the company
’s CEO, George Scangos on today’s conference call. Exelixis lost 22% of
its value on Thursday after announcing that GlaxoSmithKline (GSK) had
decided not to license additional candidates included in the joint
development collaboration between the two companies. This is certainly not a
positive development for E |
|
p***o
发帖数: 714 | 4 【 以下文字转载自 Stockcafeteria 俱乐部 】
发信人: jhsph07 (银杏), 信区: Stockcafeteria
标 题: Re: ZT: EXEL
发信站: BBS 未名空间站 (Mon Jul 6 11:51:53 2009, 美东)
基本的意思是说， EXEL是做KI的， KI的成功率大概是４０％左右， EXEL的pipeline
上面大概有11个KI， 如果按统计规律， 应该有5个最后会被FDA
批准。
等果实最终成熟大概还需要两年的时间。
Exelixis proves skeptics wrong
Dec 19, 2008
Another company that gives its shareholders reasons to smile is Exelixis, following the mammoth deal with BMS. Exelixis licensed its most advanced compound, XL184, and its early stage RAF inhibitor, XL281 in a de... 阅读全帖 |
|
|
